We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.05B
AUM Growth
-$155M
Cap. Flow
-$184M
Cap. Flow %
-17.63%
Top 10 Hldgs %
34.16%
Holding
172
New
39
Increased
26
Reduced
59
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Financials 19.39%
3 Technology 17.32%
4 Consumer Discretionary 15.59%
5 Real Estate 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBDC icon
26
Golub Capital BDC
GBDC
$3.22B
$12.2M 1.16%
693,939
SNNA
27
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$12.2M 1.16%
647,357
-137,952
-18% -$2.41M
ARMO
28
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
$12M 1.15%
+328,351
New +$13.8M
META icon
29
Meta Platforms (Facebook)
META
$1.72T
$11.3M 1.08%
70,915
-74,265
-51% -$13.3M
LOGM
30
DELISTED
LogMein, Inc.
LOGM
$11M 1.05%
95,334
-7,890
-8% -$960K
CRM icon
31
Salesforce
CRM
$210B
$11M 1.05%
94,300
-56,800
-38% -$6.52M
TDOC icon
32
Teladoc Health
TDOC
$1.19B
$10.9M 1.04%
+269,700
New +$10.2M
WB icon
33
Weibo
WB
$1.62B
$10.8M 1.03%
+90,300
New +$11.5M
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.5M 1.01%
499,624
-200,326
-29% -$3.9M
ESRX
35
DELISTED
Express Scripts Holding Company
ESRX
$10.5M 1%
151,400
-60,900
-29% -$4.65M
TSLX icon
36
Sixth Street Specialty
TSLX
$1.7B
$10.4M 1%
583,211
+20,700
+4% +$388K
MPWR icon
37
Monolithic Power Systems
MPWR
$56.6B
$10.4M 0.99%
+89,500
New +$10.6M
LRCX icon
38
Lam Research
LRCX
$342B
$10.2M 0.98%
502,400
-689,900
-58% -$13.7M
MIME
39
DELISTED
Mimecast Limited
MIME
$10.1M 0.97%
+285,900
New +$9.72M
ALGN icon
40
Align Technology
ALGN
$10.5B
$9.88M 0.95%
39,335
-1,410
-3% -$362K
LADR
41
Ladder Capital
LADR
$1.22B
$9.85M 0.94%
653,478
-88,600
-12% -$1.3M
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$130B
$9.62M 0.92%
59,042
-6,640
-10% -$1.08M
AMGN icon
43
Amgen
AMGN
$203B
$9.08M 0.87%
+53,240
New +$9.77M
AVNS
44
DELISTED
Avanos Medical
AVNS
$8.89M 0.85%
+192,900
New +$9.16M
ILMN icon
45
Illumina
ILMN
$34.5B
$8.88M 0.85%
+38,632
New +$8.85M
GWPH
46
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$8.75M 0.84%
77,691
+4,820
+7% +$606K
CELG
47
DELISTED
Celgene Corp
CELG
$8.58M 0.82%
96,147
-6,900
-7% -$662K
AEIS icon
48
Advanced Energy
AEIS
$10.3B
$8.48M 0.81%
+132,700
New +$9.17M
BMY icon
49
Bristol-Myers Squibb
BMY
$131B
$8.44M 0.81%
133,460
+5,100
+4% +$328K
PHM icon
50
Pultegroup
PHM
$22.7B
$8.03M 0.77%
272,194
-73,100
-21% -$2.27M

Similar funds

Clough Capital Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Clough Capital Partners held 172 positions worth $1.05B, down 13% from $1.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Clough Capital Partners withdrew a net $184M in Q1 2018, closing 37 positions and reducing 59 holdings. Its most notable exit was Liberty Broadband Class C, an estimated $48.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, Clough Capital Partners opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $48.4M.

  • Clough Capital Partners's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 916,092 shares worth $48.4M.
  • Clough Capital Partners added most to Lennar Class A in Q1 2018, an estimated $8.31M increase.
  • Clough Capital Partners's biggest Q1 2018 reduction was Bank of America, cutting an estimated $23.6M.
  • Clough Capital Partners fully exited Liberty Broadband Class C in Q1 2018, selling an estimated $48.9M.
  • Clough Capital Partners's ten largest holdings make up 34% of its $1.05B portfolio in Q1 2018.
  • Clough Capital Partners opened 39 new positions and closed 37 in Q1 2018.
  • Clough Capital Partners's portfolio value fell 13% quarter-over-quarter to $1.05B.

Based on Clough Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.